Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06061757 · ClinicalTrials.gov registry record · NA
Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure
A NA study of Stroke and Atrial Fibrillation, sponsored by Kansas City Heart Rhythm Research Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT06061757: Recruiting NA study of Stroke and Atrial Fibrillation, sponsored by Kansas City Heart Rhythm Research Foundation.
NCT06061757 is a NA study of Stroke and Atrial Fibrillation that is actively recruiting participants, run by Kansas City Heart Rhythm Research Foundation. The registered enrollment target is 52 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06061757, a NA study of Stroke and Atrial Fibrillation, is actively recruiting participants, sponsored by Kansas City Heart Rhythm Research Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, single center, non-randomized study with two parallel arms intended to study if 4D Intracardiac echocardiography (4D-ICE) (Nuvision, Nuvera TM) will provide better visualization of the anatomical landmarks from the larger imaging volume and provide optimal intra procedural guidance similar to Transesophageal echocardiography (TEE) (GE 6VT-D ULTRASOUND TRANSDUCER) for Left atrial appendage closure (LAAC). The study will enroll approximately 52 subjects and will be followed through 12 months.
Primary Outcome
Success of Implantation of Amulet or Watchman FLX device
Conditions Studied
Interventions
- DEVICE Imaging guidance with TEE and ICE for Left atrial appendage closure
Study Locations (1)
Kansas
- Kansas City Heart Rhythm Institute - Roe Clinic - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT06061757 shows while recruiting
NCT06061757 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Imaging guidance with TEE and ICE for Left atrial appendage closure is the first listed.
NCT06061757 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06061757 about?
NCT06061757 is a clinical study titled "Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure". This is a prospective, single center, non-randomized study with two parallel arms intended to study if 4D Intracardiac echocardiography (4D-ICE) (Nuvision, Nuvera TM) will provide better visualization of the anatomical landmarks from the larger imaging volume and provide optimal intra procedural gui...
What is the current status of trial NCT06061757?
This trial is currently recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2023-05-10. Estimated completion is 2025-12-31.
What conditions does trial NCT06061757 study?
This clinical trial studies the following conditions: Stroke, Atrial Fibrillation.
What interventions are being tested in trial NCT06061757?
The interventions under investigation include: Imaging guidance with TEE and ICE for Left atrial appendage closure (DEVICE).
Who is sponsoring clinical trial NCT06061757?
This trial is sponsored by Kansas City Heart Rhythm Research Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06061757 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06061757's enrollment target sits among peer trials
52 230th of 454 higher than 225 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI